Loading
A phase 2 trial of cyclophosphamide, epirubicin, docetaxel, carboplatin and other drugs in triple-negative breast cancer, run by University of Chicago, now recruiting.
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer is a phase 2, interventional study registered as NCT06291064 by University of Chicago, with a registry enrolment figure of 85 participants, started 2025-03-18 and due to reach its primary completion in 2029-06. Interventions recorded: Cyclophosphamide; Epirubicin; Docetaxel; Carboplatin; Breast Surgery; Capecitabine. Conditions listed: Triple Negative Breast Cancer. Triple-negative eligibility wording from the registry: "Patients with histologically confirmed carcinoma of the female breast with triple-negative status by immunohistochemistry (IHC)". Sites: Nigeria. No results are recorded here; the registry entry is the source.
Shares Epirubicin, Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Epirubicin, Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Epirubicin, Capecitabine, Cyclophosphamide, Early triple-negative breast cancer and the tag tnbc-deep-dive.
Shares Epirubicin, Docetaxel, Cyclophosphamide, Early triple-negative breast cancer and the tag tnbc-deep-dive.
Shares Epirubicin, Docetaxel, Cyclophosphamide, Early triple-negative breast cancer and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Docetaxel, Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.